OBJECTIVETo analyse the prognostic value of the percentage of positive biopsy cores (PPBC) in determining the pathological features and biochemical outcome of patients with prostate cancer treated by radical prostatectomy, as published data evaluating the prognostic value of PPBC in such patients have limitations.PATIENTS and METHODSA group of 534 patients with clinically localized prostate cancer was selected. the PPBC was defined as the number of positive biopsy cores/total number of biopsy cores x 100, and grouped into categories of <25%, 25.1-50%, 50.1-75% and 75.1-100%. Patients were divided in low-, intermediate- and high-risk groups according to the usual variables.RESULTSThe mean follow-up was 60.5 months. PPBC was associated with t...
<p><strong>Objective: </strong>to determine the rate of prostate cancer (PC) development after repea...
Abstract Background Many urologic surgeons refer to biopsy core details for decision making in cases...
Background/aim(s)To determine the impact of post-treatment biopsy results on 10-year metastasis-free...
OBJECTIVE: To assess the prognostic value of the percentage of positive fragments (PPF) in biopsies ...
AbstractThe aim of this study was to evaluate the correlation among various preoperative clinical va...
Background: Number of positive prostate biopsy cores represents a key determinant between high versu...
Objectives: To identify predictive factors of unfavorable disease and of biochemical failure in pati...
OBJECTIVES To examine the effect the number of biopsy cores taken has on the rate of clinically sign...
Objective To test the hypothesis that spatial distribution of positive cores at biopsy is a predicto...
Purpose: We compare the ability of total prostate specific antigen (PSA), percent free PSA, PSA dens...
OBJECTIVE To assess whether the number of cores at first prostate biopsy affect pathologic findings ...
Background. Targeted biopsy is proposed as a method of choice in the algorithm of prostate cancer di...
INTRODUCTION: The need for defining the extension of disease in patients undergoing radical prostate...
Purpose: Patients with a single microfocus of prostate cancer at initial biopsy represent the ideal ...
Context.-Studies analyzing the concordance of biopsy and radical prostatectomy (RP) Gleason scores h...
<p><strong>Objective: </strong>to determine the rate of prostate cancer (PC) development after repea...
Abstract Background Many urologic surgeons refer to biopsy core details for decision making in cases...
Background/aim(s)To determine the impact of post-treatment biopsy results on 10-year metastasis-free...
OBJECTIVE: To assess the prognostic value of the percentage of positive fragments (PPF) in biopsies ...
AbstractThe aim of this study was to evaluate the correlation among various preoperative clinical va...
Background: Number of positive prostate biopsy cores represents a key determinant between high versu...
Objectives: To identify predictive factors of unfavorable disease and of biochemical failure in pati...
OBJECTIVES To examine the effect the number of biopsy cores taken has on the rate of clinically sign...
Objective To test the hypothesis that spatial distribution of positive cores at biopsy is a predicto...
Purpose: We compare the ability of total prostate specific antigen (PSA), percent free PSA, PSA dens...
OBJECTIVE To assess whether the number of cores at first prostate biopsy affect pathologic findings ...
Background. Targeted biopsy is proposed as a method of choice in the algorithm of prostate cancer di...
INTRODUCTION: The need for defining the extension of disease in patients undergoing radical prostate...
Purpose: Patients with a single microfocus of prostate cancer at initial biopsy represent the ideal ...
Context.-Studies analyzing the concordance of biopsy and radical prostatectomy (RP) Gleason scores h...
<p><strong>Objective: </strong>to determine the rate of prostate cancer (PC) development after repea...
Abstract Background Many urologic surgeons refer to biopsy core details for decision making in cases...
Background/aim(s)To determine the impact of post-treatment biopsy results on 10-year metastasis-free...